The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction

Murat Selçuk1, Tufan Çınar1, Faysal Şaylık2

  • 1Department of Cardiology, Sultan II. Abdülhamid Han Training and Research Hospital, Health Sciences University, Istanbul, Turkey.

Angiology
|April 21, 2021
PubMed

Insights

The PRECISE-DAPT score, predicting bleeding complications, was significantly higher in ST-elevation myocardial infarction (STEMI) patients who experienced no-reflow after percutaneous coronary intervention (PCI). Higher scores also correlated with worse outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • ST-elevation myocardial infarction (STEMI) requires prompt reperfusion therapy.
  • Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
  • Predicting complications like no-reflow (NR) is crucial for patient management.

Purpose of the Study:

  • To assess the association between the PRECISE-DAPT score and the incidence of no-reflow (NR) in STEMI patients undergoing primary PCI.
  • To investigate the relationship between the PRECISE-DAPT score and adverse clinical outcomes in this patient cohort.

Main Methods:

  • Observational, retrospective study including 335 STEMI patients treated with primary PCI.
  • Patients were stratified based on a PRECISE-DAPT score of <25 versus ≥25.
  • Multivariable analysis was employed to determine independent predictors of NR.

Main Results:

  • No-reflow (NR) occurred in 8.9% of patients.
  • Patients who developed NR had a significantly higher mean PRECISE-DAPT score (20.03 vs 11.33; P = .005).
  • A PRECISE-DAPT score ≥25 was associated with increased arrhythmic complications, in-hospital shock, and mortality. The score was independently linked to NR (OR: 2.87, P = .015).

Conclusions:

  • The PRECISE-DAPT score is a significant predictor of no-reflow (NR) in STEMI patients undergoing primary PCI.
  • Higher PRECISE-DAPT scores are associated with increased risk of NR and adverse in-hospital outcomes.
  • This study provides novel insights into the utility of the PRECISE-DAPT score beyond bleeding risk prediction.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
242
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
68
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
110